Minerva Neurosciences, Inc.

NERV·NasdaqCM·Healthcare
Compare
2.5700+0.2200 (+9.36%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.3500
Open2.4100
Day range2.39002.6300
52-week range1.96008.8000
Off day high−2.28%
Off 52-week high−70.80%
Volume308.62K
Avg. volume (3M)192.31K
Market cap122.71M
EPS (TTM)-36.12
Forward P/E-6.12
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.01
Shares outstanding47.75M
Short interest5.28% of float
Earnings dateAug 5, 2025 (est.)
Analyst target10.3333
Profit margin0.00%

Against its peers

Compare in full ›
NERV NSB.AX NP5.F NMRA VYGR QNTM
Market cap 122.71M 21.04M 205.50M 106.35M 115.23M 14.21M
P/E (TTM) — — — — — —
Forward P/E -6.1 — — -0.9 -1.5 -0.3
Price/book -0.6 1.4 -17.9 2.4 0.7 2.1
Dividend yield — — — — — —
1-year change −38.48% −65.52% −38.08% −78.21% −57.14% −75.44%
Today +9.36% 0.00% −0.50% −0.86% +2.19% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All NERV news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance